0001661181-20-000029.txt : 20200825
0001661181-20-000029.hdr.sgml : 20200825
20200825163418
ACCESSION NUMBER: 0001661181-20-000029
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200821
FILED AS OF DATE: 20200825
DATE AS OF CHANGE: 20200825
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hagopian Henry III
CENTRAL INDEX KEY: 0001821822
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37906
FILM NUMBER: 201132660
MAIL ADDRESS:
STREET 1: C/O ORGANOGENESIS INC., 85 DAN ROAD
CITY: CANTON
STATE: MA
ZIP: 02021
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Organogenesis Holdings Inc.
CENTRAL INDEX KEY: 0001661181
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 85 DAN ROAD
CITY: CANTON
STATE: MA
ZIP: 02021
BUSINESS PHONE: 781-575-0775
MAIL ADDRESS:
STREET 1: 85 DAN ROAD
CITY: CANTON
STATE: MA
ZIP: 02021
FORMER COMPANY:
FORMER CONFORMED NAME: Avista Healthcare Public Acquisition Corp.
DATE OF NAME CHANGE: 20151215
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2020-08-21
0001661181
Organogenesis Holdings Inc.
ORGO
0001821822
Hagopian Henry III
C/O ORGANOGENESIS HOLDINGS INC.
85 DAN ROAD
CANTON
MA
02021
0
1
0
0
Interim CFO
Stock Option (Right to Buy)
4.46
2020-08-21
4
A
0
15000
0
A
2030-08-21
Class A Common Stock
15000
15000
D
The option becomes exercisable in equal yearly installments over four years from the date of grant.
/s/ Stacie S. Aarestad, Attorney-in-Fact
2020-08-25